childhood
pneumonia
major
contributor
mortal
especi
develop
countri
western
pacif
region
highest
burden
childhood
pneumonia
pneumoniarel
death
occur
six
countri
cambodia
china
lao
papua
new
guinea
philippin
vietnam
countri
report
least
pneumonia
episod
per
child
time
rate
report
develop
countri
region
australia
new
zealand
japan
manag
childhood
pneumonia
problemat
set
microbiolog
diagnosi
rare
pursu
drug
resist
profil
common
bacteria
caus
respiratori
diseas
readili
avail
mani
asian
countri
encourag
excess
use
broadspectrum
antibiot
irrespect
child
diseas
sever
author
experi
children
frequent
hospit
pneumonia
administ
intraven
antibiot
despit
rel
mild
diseas
unnecessari
hospit
intraven
antibiot
increas
healthcar
cost
well
treatmentrel
complic
likelihood
nosocomi
diseas
transmiss
order
encourag
ration
use
intraven
antibiot
children
communityacquir
pneumonia
author
perform
comprehens
review
common
bacteri
pathogen
report
drug
resist
profil
western
pacif
particular
factor
increas
unnecessari
antibiot
use
measur
might
reduc
use
also
consid
pubm
googl
scholar
embas
databas
search
use
follow
term
antibacteri
agent
antibiot
drug
therapi
commun
acquir
pneumonia
acut
respiratori
tract
infect
child
children
childhood
manuscript
titl
abstract
review
identifi
origin
research
paper
includ
children
less
year
age
pneumonia
geograph
focu
vietnam
western
pacif
region
addit
refer
select
public
review
coauthor
suggest
addit
relev
paper
term
acut
respiratori
tract
infect
arti
describ
acut
infect
involv
lung
airway
upper
lower
world
health
organ
defin
pneumonia
child
tachypnoea
without
sign
respiratori
distress
given
huge
overlap
term
appli
clinic
practic
author
consid
pneumonia
acut
lower
respiratori
tract
infect
lrti
synonym
purpos
review
develop
resist
mutat
multipl
antibiot
well
document
pneumonia
well
expans
resist
clone
antibiot
pressur
resist
record
penicillin
tetracyclin
cotrimoxazol
chloramphenicol
fluoroquinolon
macrolid
although
correl
vitro
vivo
resist
remain
contenti
gener
assum
penicillin
adequ
dosag
still
effect
pneumococc
pneumonia
mening
caus
strain
low
intermedi
level
resist
vitro
difficult
verifi
mani
factor
influenc
outcom
pneumonia
underli
comorbid
condit
diseas
sever
support
poorli
describ
histor
dataset
adequ
power
headtohead
comparison
rare
anoth
import
factor
take
consider
rollout
pneumococc
conjug
vaccin
routin
administr
pneumococc
conjug
vaccin
pcv
infanc
led
major
reduct
pneumonia
hospit
invas
pneumococc
diseas
young
children
given
common
drug
resist
strain
includ
pneumococc
conjug
vaccin
drug
resist
pneumococc
diseas
greatli
reduc
area
high
vaccin
uptak
reduct
strain
carriag
also
reduc
secondari
pneumonia
case
among
older
adult
howev
recent
studi
canada
unit
kingdom
demonstr
substanti
increas
multidrug
resist
nonvaccin
serotyp
colon
invas
strain
sinc
introduc
similar
find
colon
strain
introduc
korean
children
high
penicillin
macrolid
resist
rate
report
publish
survey
mani
survey
includ
select
patient
popul
use
minim
inhibitori
concentr
mic
breakpoint
variabl
stringenc
also
done
prior
routin
pcv
deliveri
use
variabl
mic
breakpoint
differ
studi
major
sourc
confus
complic
studi
comparison
mic
breakpoint
defin
clinic
laboratori
standard
institut
clsi
wide
use
unit
state
europ
adopt
european
committe
antimicrobi
suscept
test
eucast
standard
use
broadli
similar
vitro
method
specifi
mic
breakpoint
consid
pkpd
properti
drug
clinic
site
diseas
specif
mechan
drug
resist
studi
shown
reason
compar
antibiot
suscept
profil
use
revis
clsi
eucast
breakpoint
signific
differ
remain
pneumonia
h
influenza
cefuroxim
cefaclor
breakpoint
still
produc
diverg
result
global
surveil
effort
would
greatli
enhanc
uniform
surveil
criteria
agre
upon
mic
breakpoint
definit
harmon
studi
conduct
asian
countri
report
low
preval
penicillin
resist
pneumonia
nonmening
isol
use
mic
breakpoint
recommend
clsi
much
higher
breakpoint
propos
eucast
small
case
seri
children
pneumonia
septicemia
china
report
high
drug
resist
rate
mic
breakpoint
specifi
malaysia
pneumonia
isol
blood
children
communityacquir
pneumonia
resist
penicillin
use
revis
clsi
breakpoint
sinc
nasopharyng
carriag
may
creat
reservoir
resist
pneumonia
clone
import
monitor
resist
carriag
specimen
well
nasopharyng
pneumonia
carriag
report
healthi
chines
children
resist
macrolid
etest
method
rural
vietnam
pneumonia
carriag
detect
children
higher
rate
less
year
age
month
resist
rate
amoxicillin
benzylpenicillin
low
base
revis
clsi
breakpoint
resist
least
one
antibiot
cotrimoxazol
erythromycin
ciprofloxacin
recent
vietnames
survey
confirm
excel
penicillin
suscept
pneumonia
isol
respiratori
specimen
penicillin
use
revis
clsi
breakpoint
although
cephalosporin
macrolid
suscept
poor
cefuroxim
cefaclor
azithromycin
support
vietnam
nation
guidanc
use
high
dose
mgkgday
amoxicillin
firstlin
treatment
communityacquir
pneumonia
children
although
preval
h
influenza
type
b
hib
declin
dramat
widespread
rollout
conjug
hib
vaccin
remain
preval
set
poor
vaccin
uptak
blactamas
product
commonli
associ
hib
infect
vietnam
respiratori
hib
isol
produc
nonproduc
ampicillinresist
howev
imposs
differenti
clinic
infect
asymptomat
colon
use
respiratori
specimen
nonsteril
site
china
hib
carriag
decreas
isol
increas
time
period
amoxicillinclavulan
acid
gener
cephalosporin
remain
univers
effect
despit
nation
hib
vaccin
rollout
vietnam
hib
remain
common
invas
pathogen
expect
decreas
vaccin
uptak
improv
increas
vaccin
uptak
role
encapsul
h
influenza
strain
increas
studi
china
found
h
influenza
strain
identifi
sputum
children
pneumonia
nontyp
nonproduc
ampicillinresist
intermedi
resist
aureu
remain
common
caus
communityacquir
pneumonia
pioneer
lung
punctur
studi
perform
chile
papua
new
guinea
identifi
aureu
common
pathogen
children
communityacquir
pneumonia
recent
studi
found
pathogen
predominantli
children
sever
end
pneumonia
diseas
spectrum
increas
frequenc
sever
malnourish
children
aureu
also
pose
particular
problem
follow
influenza
measl
infect
secondari
infect
hospit
children
major
challeng
emerg
methicillinresist
aureu
mrsa
recent
decreas
vancomycin
suscept
among
posit
aureu
blood
cultur
australian
new
zealand
children
mrsa
report
three
time
averag
rate
incid
rate
ratio
ci
found
among
aborigin
pacif
island
popul
recent
malaysian
survey
report
mrsa
children
communityacquir
aureu
bacteremia
skin
soft
tissu
infect
communityacquir
pneumonia
studi
assess
preval
heterogen
vancomycinintermediatelyresist
aureu
hvisa
asian
countri
includ
south
korea
taiwan
hong
kong
thailand
philippin
vietnam
india
sri
lanka
report
among
mrsa
isol
hvisa
highest
preval
south
korea
vietnam
extens
report
antibiot
resist
hospit
throughout
vietnam
found
mrsa
children
adult
aureu
bacteremia
vancomycin
resist
rate
low
mycoplasma
pneumonia
highli
preval
children
diagnos
pneumonia
western
pacif
region
pneumonia
inher
resist
antibiot
vancomycin
cell
wall
excess
macrolid
use
recent
year
report
macrolid
resist
near
univers
part
asia
countri
report
high
rate
macrolid
resist
japan
china
south
korea
hong
kong
taiwan
although
method
pneumonia
suscept
test
poorli
standard
pneumonia
remain
suscept
macrolid
australia
less
frequent
use
resist
tetracyclin
fluoroquinolon
report
clinic
isol
may
provid
treatment
altern
children
although
reduc
vitro
suscept
report
howev
pneumonia
case
recov
either
without
antibiot
treatment
despit
document
drug
resist
thu
clinic
valu
antibiot
treatment
remain
uncertain
treatment
arti
major
driver
antibiot
use
children
import
clinician
familiar
common
bacteri
caus
local
drug
resist
profil
like
impact
antibiot
therapi
posit
neg
order
develop
ration
treatment
approach
time
definit
bacteriolog
diagnosi
current
imposs
empir
antibiot
treatment
justifi
acut
ill
child
howev
need
critic
consid
factor
promot
unnecessari
irrat
antibiot
use
especi
children
acut
ill
given
unrestrict
access
overthecount
antibiot
treatment
respiratori
infect
antibiot
common
practic
vietnam
malaysia
south
korea
vietnam
pharmaceut
law
pass
requir
antibiot
prescript
caregiv
still
access
antibiot
without
formal
medic
assess
even
inject
antibiot
acquir
local
shop
without
prescript
western
pacif
region
antibiot
use
present
doctor
common
mongolia
children
admit
arti
philippin
studi
nine
intern
ghana
india
mexico
pakistan
south
africa
site
vietnam
use
antibiot
h
prior
hospit
admiss
associ
treatment
failur
ci
addit
agricultur
use
antibiot
remain
essenti
unregul
asian
countri
high
rate
colistin
cephalosporin
use
pig
poultri
industri
result
increas
rate
drugresist
infect
human
popul
limit
awar
among
gener
public
includ
politician
challeng
set
recent
launch
program
increas
awar
antimicrobi
resist
need
prudent
antibiot
use
respons
countryspecif
strategi
limit
antimicrobi
resist
launch
unit
kingdom
unit
state
australia
asian
countri
follow
suit
unrealist
public
expect
major
factor
drive
excess
antibiot
use
studi
rural
vietnam
show
caregiv
correct
knowledg
acut
respiratori
infect
caregiv
selfmanag
common
cold
buy
antibiot
without
prescript
local
pharmaci
malaysia
peopl
believ
antibiot
effect
viral
infect
use
antibiot
common
cold
moreov
antibiot
use
strongli
influenc
cultur
prefer
belief
patient
vietnam
china
believ
inject
antibiot
potent
oral
option
readili
access
inject
antibiot
without
prescript
lack
adequ
knowledg
also
problem
among
healthcar
provid
studi
vietnam
demonstr
poor
awar
risk
consequ
drug
resist
among
rural
healthcar
provid
treat
arti
compli
recommend
guidelin
use
antibiot
common
cold
tabl
provid
overview
physicianrel
factor
explain
excess
antibiot
use
seen
vietnam
part
western
pacif
region
difficulti
accur
differenti
viral
bacteri
pneumonia
major
challeng
set
studi
finland
show
routin
blood
test
creactiv
protein
crp
level
differ
significantli
bacteri
viral
pneumonia
patient
children
dens
lobar
infiltr
chest
radiograph
laboratori
evid
bacteri
infect
interstiti
infiltr
seen
viral
bacteri
pneumonia
recent
randomizedcontrol
trial
vietnam
show
pointofcar
crp
test
reduc
inappropri
antibiot
use
nonsever
arti
previou
randomizedcontrol
trial
china
investig
whether
serum
procalcitonin
pct
could
reduc
unnecessari
antibiot
use
although
mean
durat
antibiot
treatment
shorter
pct
group
antibiot
prescript
rate
higher
hope
rapid
pointofcar
test
common
respiratori
virus
biomark
sever
bacteri
infect
offer
better
bedsid
guidanc
near
futur
assist
appropri
antibiot
use
child
pneumonia
death
caus
bacteri
pathogen
current
guidelin
recommend
antibiot
use
pneumonia
case
defin
presenc
fast
breath
approach
may
encourag
overus
antibiot
especi
children
without
danger
sign
present
wheez
sign
reactiv
airway
diseas
usual
indic
viral
infect
audibl
wheez
note
vietnames
children
admit
pneumonia
may
identifi
subgroup
requir
antibiot
guidelin
previous
advis
intraven
antibiot
children
diagnos
sever
pneumonia
sign
respiratori
distress
oral
amoxicillin
found
effect
children
clinic
diagnosi
sever
pneumonia
pakistan
subsequ
trial
demonstr
homebas
treatment
appli
wide
varieti
set
multicent
studi
conduct
bangladesh
egypt
ghana
vietnam
report
ci
treatment
failur
day
high
dose
oral
amoxicillin
mgkgday
vari
ci
ghana
ci
vietnam
sizeabl
unknown
proport
case
enrol
clinic
pneumonia
studi
would
viral
infect
therefor
clear
much
treatment
failur
actual
result
inadequ
antibiot
treatment
bacteri
pneumonia
children
found
unrespons
antibiot
probabl
viral
pneumonia
despit
avail
evid
doctor
vietnam
routin
hospit
children
clinic
pneumonia
administ
intraven
antibiot
unnecessari
hospit
increas
healthcar
cost
risk
nosocomi
infect
action
recommend
improv
ration
antibiot
use
commun
hospit
environ
summar
tabl
unrestrict
antibiot
access
selfmed
firmli
entrench
vietnam
asian
countri
given
multipl
vest
interest
protect
statu
quo
strong
regul
effect
law
enforc
requir
limit
excess
antibiot
use
addit
public
educ
program
better
train
healthcar
provid
critic
review
need
antibiot
use
essenti
countri
western
pacif
region
report
high
awar
antimicrobi
resist
among
healthcar
provid
educ
program
indonesia
includ
facetofac
clinician
visit
group
discuss
significantli
reduc
use
inject
drug
replic
elsewher
facilit
meet
western
pacif
region
countri
manila
identifi
feasibl
antimicrobi
resist
amr
strategi
yet
translat
revis
childhood
pneumonia
guidanc
manag
practic
vietnam
vietnam
resist
vinar
project
aim
strengthen
laboratori
surveil
reduc
irrat
antibiot
use
project
cover
particip
hospit
outsid
particip
hospit
amr
surveil
remain
weak
laboratori
capac
assist
microbiolog
diagnosi
guid
clinic
manag
insuffici
throughout
region
function
antibiot
stewardship
program
establish
countri
becom
standard
practic
adapt
local
context
antibiot
stewardship
program
chines
hospit
set
target
antibiot
prescript
penal
doctor
prescrib
antibiot
inappropri
year
antibiot
prescript
decreas
inpati
outpati
antimicrobi
stewardship
program
current
implement
vietnam
vinar
scope
program
limit
need
similar
program
includ
regular
audit
antibiot
use
everi
hospit
optim
child
pneumonia
manag
present
opportun
reduc
excess
antibiot
use
western
pacif
region
howev
encourag
ration
use
antibiot
requir
educ
healthcar
profession
facilit
cultur
chang
improv
clinic
guidanc
establish
function
microbiolog
laboratori
monitor
diseas
etiolog
drug
resist
pattern
togeth
remov
inappropri
incent
effect
enforc
nation
regul
restrict
antibiot
use
healthcar
agricultur
